Literature DB >> 18984626

Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).

Hiroki Yokoyama1, Hirohito Sone, Mariko Oishi, Koichi Kawai, Yoshihide Fukumoto, Masashi Kobayashi.   

Abstract

BACKGROUND: Microalbuminuria is widely accepted as the first clinical sign of diabetic nephropathy. However, normoalbuminuric type 2 diabetic patients who have renal insufficiency (RI), i.e. low estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m(2), exist. We explored the prevalence of such patients and associated clinical factors.
METHODS: We investigated the distribution of patients when stratified by albuminuria stages and chronic kidney disease (CKD) stages in a large-scale population of Japanese type 2 diabetic patients (N = 3297), and the common and independent factors for albuminuria and low eGFR.
RESULTS: The proportion of subjects with low eGFR was 15.3% (506/3297), which was 11.4% among those with normoalbuminuria (NA) (262/2298), 14.9% among those with microalbuminuria (105/705) and 47.3% among those with macroalbuminuria (139/294). There were 262 patients with NA and low eGFR, and 63.4% of them had neither diabetic retinopathy nor neuropathy. They were older and included a higher proportion of women and patients with hypertension, hyperlipidaemia and cardiovascular disease (CVD), and fewer smokers compared with those with NA and preserved eGFR. Multiple logistic regression analysis revealed that factors commonly associated with RI and albuminuria were hypertension, CVD and proliferative retinopathy. Factors independently associated with RI were age, duration of diabetes, A1C (negative), hyperlipidaemia, smoking (negative) and macroalbuminuria, whereas those associated with albuminuria were male sex, BMI, A1C, simple retinopathy and RI.
CONCLUSIONS: A significant proportion of type 2 diabetic patients have normoalbuminuric RI. Renal disease in type 2 diabetes could be heterogeneous, implying the possibility of involvement of renal atherosclerosis and lipid toxicity.

Entities:  

Mesh:

Year:  2008        PMID: 18984626     DOI: 10.1093/ndt/gfn603

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  66 in total

1.  Factors associated with diabetic nephropathy in subjects with proliferative retinopathy.

Authors:  Caroline Jane Magri; Neville Calleja; Gerald Buhagiar; Stephen Fava; Josanne Vassallo
Journal:  Int Urol Nephrol       Date:  2011-04-24       Impact factor: 2.370

Review 2.  Clinical impact of albuminuria in diabetic nephropathy.

Authors:  Takashi Wada; Miho Shimizu; Tadashi Toyama; Akinori Hara; Shuichi Kaneko; Kengo Furuichi
Journal:  Clin Exp Nephrol       Date:  2011-08-10       Impact factor: 2.801

Review 3.  Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors.

Authors:  Tomohito Gohda; Yasuhiko Tomino
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

Review 4.  Novel urinary biomarkers in early diabetic kidney disease.

Authors:  Atsuko Kamijo-Ikemori; Takeshi Sugaya; Kenjiro Kimura
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

5.  Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program.

Authors:  Brendon L Neuen; Toshiaki Ohkuma; Bruce Neal; David R Matthews; Dick de Zeeuw; Kenneth W Mahaffey; Greg Fulcher; Qiang Li; Meg Jardine; Richard Oh; Hiddo L Heerspink; Vlado Perkovic
Journal:  J Am Soc Nephrol       Date:  2019-09-17       Impact factor: 10.121

6.  The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study.

Authors:  Michael S Simonson; Margaret Tiktin; Sara M Debanne; Mahboob Rahman; Bruce Berger; Donald Hricik; Faramarz Ismail-Beigi
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-28

Review 7.  Normoalbuminuric diabetic kidney disease.

Authors:  Chao Chen; Chang Wang; Chun Hu; Yachun Han; Li Zhao; Xuejing Zhu; Li Xiao; Lin Sun
Journal:  Front Med       Date:  2017-07-18       Impact factor: 4.592

8.  Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation.

Authors:  Kengo Furuichi; Miho Shimizu; Tadashi Toyama; Daisuke Koya; Yoshitaka Koshino; Hideharu Abe; Kiyoshi Mori; Hiroaki Satoh; Masahito Imanishi; Masayuki Iwano; Hiroyuki Yamauchi; Eiji Kusano; Shouichi Fujimoto; Yoshiki Suzuki; Seiya Okuda; Kiyoki Kitagawa; Yasunori Iwata; Shuichi Kaneko; Shinichi Nishi; Hitoshi Yokoyama; Yoshihiko Ueda; Masakazu Haneda; Hirofumi Makino; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-02-28       Impact factor: 2.801

9.  Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension.

Authors:  Hiroki Yokoyama; Sakiko Kanno; Suguho Takahashi; Daishiro Yamada; Hiroshi Itoh; Kazumi Saito; Hirohito Sone; Masakazu Haneda
Journal:  Clin J Am Soc Nephrol       Date:  2009-09       Impact factor: 8.237

10.  Joint Modeling of Covariates and Censoring Process Assuming Non-Constant Dropout Hazard.

Authors:  Miran A Jaffa; Ayad A Jaffa
Journal:  Stat Methods Appt       Date:  2015-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.